Dr. Peter A. Kaufman, MD

Dr. Kaufman practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Kaufman's NPI, 1336151141, was assigned on August 12, 2006. Dr. Kaufman graduated from New York University School of Medicine in 1983. Dr. Kaufman's New Hampshire license number on file is 8676.

Dr. Kaufman's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Kaufman's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Kaufman is also affiliated with Northwestern Medical Center. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Kaufman to 2 more hospitals and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaufman practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Kaufman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kaufman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kaufman's licenses on file in 3 states: New Hampshire, Vermont and North Carolina.

Dmand AI lists breast cancer, lung cancer and multiple myeloma among the conditions Dr. Kaufman treats.

CMS data shows 592 Medicare services from Dr. Kaufman across 6 procedure codes in 2024, for 176 Medicare patients. Medicare paid $40,358 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 176 Medicare patients who saw Dr. Kaufman in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have cancer, and 64% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaufman's median patient age at 73, with 95% women.

In 2024, Dr. Kaufman wrote 482 Medicare Part D claims for 119 patients. 91% of them were for generic drugs. CMS names the drug for 368 of them, across 11 drugs with 11 or more claims each, at $424,942 in total drug cost. In 2023, CMS named 434 claims across 10 drugs.

Dr. Kaufman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaufman as offering telehealth.

Dmand AI links 63 papers to Dr. Kaufman, published from 2002 to 2025. 2014 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Receptor, ErbB-2 and Antineoplastic Combined Chemotherapy Protocols. Dr. Kaufman has published most often in Breast Cancer Res Treat. Dr. Kaufman's most frequent co-authors are Adam M. Brufsky, MD, Edith Perez, MD and Hope S. Rugo, MD.

Dmand AI links Dr. Kaufman to 5 clinical trials. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Endometrial Neoplasms. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Kaufman that name 5 trials.

CMS Open Payments shows 1,069 general payments to Dr. Kaufman from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Eli Lilly and Company paid the most, $606,710. It also lists 14 research payments totaling $6,379 from 2016 to 2023, naming 5 clinical trials.

Dr. Kaufman graduated from New York University School of Medicine in 1983.

Dr. Kaufman is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.